26 ML ustekinumab-aekn 5 MG/ML Injection
- RxCUI
- 2705382
- RxNorm name
- 26 ML ustekinumab-aekn 5 MG/ML Injection
- Display name
- 26 ML ustekinumab-aekn 5 MG/ML Injection
- Full name
- 26 ML ustekinumab-aekn 5 MG/ML Injection
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:07
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761343 | Selarsdi | ustekinumab-aekn | 351(k) Interchangeable | Rx | 2026-07-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Selarsdi | USTEKINUMAB-AEKN | Teva Pharmaceuticals USA, Inc. | 87f75b59-e48b-47c7-a4c0-5fe5965660e7 | 2026-06-24 | Warnings, Adverse reactions | 2705382 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 87f75b59-e48b-47c7-a4c0-5fe5965660e7 | ustekinumab-aekn 130 MG in 26 ML Injection [PSN] · 26 ML ustekinumab-aekn 5 MG/ML Injection [SCD] · ustekinumab-aekn 130 MG per 26 ML Injection [SY] · ustekinumab-aekn 5 MG/ML per 26 ML Injection [SY] | 4 | 13 | These highlights do not include all the information needed to use SELARSDI safely and effectively. See full prescribing information for SELARSDI. SELARSDI™ (ustekinumab-aekn) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2024 SELARSDI (ustekinumab-aekn) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaning | 20251203 |